Remote Monitoring Systems for Self-Managing Type 2 Diabetes: A Systematic Review

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

The aim of our systematic review is: to evaluate evidence for feasibility and impact of telemedicine and web-based telemonitoring for managing Type 2 Diabetes Mellitus. We used MEDLINE, EMBASE, CINAHL, AMED, Cochrane and PubMed to conduct our search using the terms: telemonitoring for type-II diabetes mellitus self-management using web-based Internet solutions. The technology used, trial design, quality of life and the Glycated haemoglobin (HbA1c) outcome measures used were extracted for systemic reviews and meta-analyses, randomised controlled trials and cohort studies. Our search identified 426 publications; 19 only publications met our search criteria. Ten quasi-experiments out of which seven are pre-post test studies, two are cohort studies and one is interrupted time-series study and nine randomised controlled trials (RCT). Electronic transfer of glucose results from home to hospital appears to be more feasible for healthcare delivery. Six of these studies were conducted in USA, six in South Korea, three in the United Kingdom, two in Taiwan and one in each of Spain, Poland and India. The duration of the studies varied from four weeks to eighteen months and the participants were all adults. Fifteen studies showed positive improvement in HbA1c levels. One study showed high acceptance of the technology among participants. In the end, it remains challenging to identify evidence in the rapidly changing area of remote monitoring in diabetes care. Both the technology and its typology are complex. The optimal design of a telemedicine system is still uncertain and the impact of the real-time blood glucose transmissions is still controversial.
LanguageEnglish
Title of host publicationUnknown Host Publication
Number of pages1
Publication statusPublished - 19 Nov 2014
EventHISI 2014 - Ireland's 19th Annual eHealth Conference - Dublin, Ireland
Duration: 19 Nov 2014 → …

Conference

ConferenceHISI 2014 - Ireland's 19th Annual eHealth Conference
Period19/11/14 → …

Fingerprint

Type 2 Diabetes Mellitus
Telemedicine
Technology
Publications
Cohort Studies
Randomized Controlled Trials
Republic of Korea
Glycosylated Hemoglobin A
Poland
Self Care
Taiwan
PubMed
MEDLINE
Internet
Spain
Blood Glucose
Meta-Analysis
India
Quality of Life
Outcome Assessment (Health Care)

Keywords

  • Type 2 diabetes
  • self-management
  • Telemonitoring
  • Telehealth
  • telemedicine
  • Connected Health Technology
  • Blood Glucose Monitoring

Cite this

@inproceedings{40373876a5dd45bc97a5aea99752c6b1,
title = "Remote Monitoring Systems for Self-Managing Type 2 Diabetes: A Systematic Review",
abstract = "The aim of our systematic review is: to evaluate evidence for feasibility and impact of telemedicine and web-based telemonitoring for managing Type 2 Diabetes Mellitus. We used MEDLINE, EMBASE, CINAHL, AMED, Cochrane and PubMed to conduct our search using the terms: telemonitoring for type-II diabetes mellitus self-management using web-based Internet solutions. The technology used, trial design, quality of life and the Glycated haemoglobin (HbA1c) outcome measures used were extracted for systemic reviews and meta-analyses, randomised controlled trials and cohort studies. Our search identified 426 publications; 19 only publications met our search criteria. Ten quasi-experiments out of which seven are pre-post test studies, two are cohort studies and one is interrupted time-series study and nine randomised controlled trials (RCT). Electronic transfer of glucose results from home to hospital appears to be more feasible for healthcare delivery. Six of these studies were conducted in USA, six in South Korea, three in the United Kingdom, two in Taiwan and one in each of Spain, Poland and India. The duration of the studies varied from four weeks to eighteen months and the participants were all adults. Fifteen studies showed positive improvement in HbA1c levels. One study showed high acceptance of the technology among participants. In the end, it remains challenging to identify evidence in the rapidly changing area of remote monitoring in diabetes care. Both the technology and its typology are complex. The optimal design of a telemedicine system is still uncertain and the impact of the real-time blood glucose transmissions is still controversial.",
keywords = "Type 2 diabetes, self-management, Telemonitoring, Telehealth, telemedicine, Connected Health Technology, Blood Glucose Monitoring",
author = "Hayat Mushcab and W.George Kernohan and Suzanne Martin",
year = "2014",
month = "11",
day = "19",
language = "English",
booktitle = "Unknown Host Publication",

}

Mushcab, H, Kernohan, WG & Martin, S 2014, Remote Monitoring Systems for Self-Managing Type 2 Diabetes: A Systematic Review. in Unknown Host Publication. HISI 2014 - Ireland's 19th Annual eHealth Conference, 19/11/14.

Remote Monitoring Systems for Self-Managing Type 2 Diabetes: A Systematic Review. / Mushcab, Hayat; Kernohan, W.George; Martin, Suzanne.

Unknown Host Publication. 2014.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

TY - GEN

T1 - Remote Monitoring Systems for Self-Managing Type 2 Diabetes: A Systematic Review

AU - Mushcab, Hayat

AU - Kernohan, W.George

AU - Martin, Suzanne

PY - 2014/11/19

Y1 - 2014/11/19

N2 - The aim of our systematic review is: to evaluate evidence for feasibility and impact of telemedicine and web-based telemonitoring for managing Type 2 Diabetes Mellitus. We used MEDLINE, EMBASE, CINAHL, AMED, Cochrane and PubMed to conduct our search using the terms: telemonitoring for type-II diabetes mellitus self-management using web-based Internet solutions. The technology used, trial design, quality of life and the Glycated haemoglobin (HbA1c) outcome measures used were extracted for systemic reviews and meta-analyses, randomised controlled trials and cohort studies. Our search identified 426 publications; 19 only publications met our search criteria. Ten quasi-experiments out of which seven are pre-post test studies, two are cohort studies and one is interrupted time-series study and nine randomised controlled trials (RCT). Electronic transfer of glucose results from home to hospital appears to be more feasible for healthcare delivery. Six of these studies were conducted in USA, six in South Korea, three in the United Kingdom, two in Taiwan and one in each of Spain, Poland and India. The duration of the studies varied from four weeks to eighteen months and the participants were all adults. Fifteen studies showed positive improvement in HbA1c levels. One study showed high acceptance of the technology among participants. In the end, it remains challenging to identify evidence in the rapidly changing area of remote monitoring in diabetes care. Both the technology and its typology are complex. The optimal design of a telemedicine system is still uncertain and the impact of the real-time blood glucose transmissions is still controversial.

AB - The aim of our systematic review is: to evaluate evidence for feasibility and impact of telemedicine and web-based telemonitoring for managing Type 2 Diabetes Mellitus. We used MEDLINE, EMBASE, CINAHL, AMED, Cochrane and PubMed to conduct our search using the terms: telemonitoring for type-II diabetes mellitus self-management using web-based Internet solutions. The technology used, trial design, quality of life and the Glycated haemoglobin (HbA1c) outcome measures used were extracted for systemic reviews and meta-analyses, randomised controlled trials and cohort studies. Our search identified 426 publications; 19 only publications met our search criteria. Ten quasi-experiments out of which seven are pre-post test studies, two are cohort studies and one is interrupted time-series study and nine randomised controlled trials (RCT). Electronic transfer of glucose results from home to hospital appears to be more feasible for healthcare delivery. Six of these studies were conducted in USA, six in South Korea, three in the United Kingdom, two in Taiwan and one in each of Spain, Poland and India. The duration of the studies varied from four weeks to eighteen months and the participants were all adults. Fifteen studies showed positive improvement in HbA1c levels. One study showed high acceptance of the technology among participants. In the end, it remains challenging to identify evidence in the rapidly changing area of remote monitoring in diabetes care. Both the technology and its typology are complex. The optimal design of a telemedicine system is still uncertain and the impact of the real-time blood glucose transmissions is still controversial.

KW - Type 2 diabetes

KW - self-management

KW - Telemonitoring

KW - Telehealth

KW - telemedicine

KW - Connected Health Technology

KW - Blood Glucose Monitoring

M3 - Conference contribution

BT - Unknown Host Publication

ER -